NCT01071941: rRp450-Phase I Trial in Liver Metastases and Primary Liver Tumors

NCT01071941
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER++, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Recruiting
Ph+ase 1
Drug Category: Immunotherapy

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Liver
Additional Notes: 
Exclusions: Patients with brain metastases
https://ClinicalTrials.gov/show/NCT01071941

Comments are closed.

Up ↑